Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study.
Phase of Trial: Phase III
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Mannitol (Primary)
- Indications Cystic fibrosis
- Focus Registrational; Therapeutic Use
- Sponsors Pharmaxis
- 28 Jul 2017 This trial was discontinued in United Kingdom.
- 26 Oct 2010 According to a Pharmaxis media release, pooled data from its 2 large scale 6-month phase III trials of mannitol in patients with cystic fibrosis have been presented at the North American Cystic Fibrosis Conference.
- 02 Jul 2010 New trial record